Home > Press > Nanoparticles and Nanodevices to be Used in Studies
CCNE will focus on the application of PRINTTM nanoparticles and nanodevices for cancer therapy and imaging
PRINTTM Nanoparticles and Nanodevices to be Used in Studies Awarded by the National Cancer Institute to the University of North Carolina Center of Cancer Nanotechnology Excellence
Research Triangle Park, NC | October 07, 2005
The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), awarded the University of North Carolina-Chapel Hill one of seven centers of cancer nanotechnology research. These centers are an integral part of a $144.3 million, five-year initiative to develop and apply nanotechnology for the detection, diagnosis, and treatment of cancer. The Carolina Center of Cancer Nanotechnology Excellence (CCNE) will focus on the application of PRINTTM nanoparticles and nanodevices for cancer therapy and imaging. The CCNE will be headed by principal investigator Professor Rudolph Juliano and co-principal investigator Professor Joseph DeSimone.
PRINTTM particle technology results in unprecedented control over shape, size, and composition of material when manufacturing nanoparticles, resulting in drug delivery systems previously unattainable. The nanodevice technology includes the development of microfluidic chips from an innovative fluoropolymer technology. These chips have a unique combination of high performance features around precision molding, chemical resistance, gas permeability, and more.
"We are thrilled at the endorsement of these technologies by the NCI as a promising new era in cancer research. We believe both technologies have the potential to radically change human health care." says Professor DeSimone, National Academy of Engineering member and co-founder of Liquidia Technologies. Liquidia is a licensee of PRINTTM particles and microfluidic technologies from the university.
The new Carolina Center of Cancer Nanotechnology Excellence will be closely associated with UNC facilities including the Lineberger Comprehensive Cancer Center, Mouse Model of Human Cancer Consortium, the Biomedical Research Imaging Center, the Institute for Advanced Materials, Nanoscience and Technology, and the College of Arts and Sciences. The newly formed Center will also partner with not-for-profit organizations and private sector firms, with the specific intent of advancing the technologies being developed.
"NCI has supported the application of nanotechnology to cancer through a variety of programs and interactions with the scientific community for more than seven years, and we're very gratified that our activities are helping to advance a pipeline of new product opportunities," noted NCI Deputy Director Anna Barker, Ph.D. in the NCI press release. "Central to this initiative will be multidisciplinary partnerships involving physicists, biologists, clinicians, engineers, and other experts that can translate knowledge on cancer and nanotechnology into clinically useful products."
For more information about the NCI Alliance on Nanotechnology in Cancer, please visit nano.cancer.gov.
About Liquidia Technologies:
Located in Research Triangle Park, North Carolina, Liquidia Technologies develops and markets innovative fluoropolymer materials for high-value industrial applications in the electronics, life science, and chemical industries. Liquidia Technologies offers solutions in microfluidics and imprint lithography applications due to the beneficial qualities of its innovative material platform including solvent resistance, low surface energy, and elastomeric properties. Liquidia Technologies also brings precision, uniformity, and mass production techniques associated with the engineering of devices found in the microelectronics industry to the nanomedicine field for the fabrication and delivery of therapeutic, detection, and imaging agents for the diagnosis and treatment of human diseases.
For more information, please click here
Bruce Boucher, President
919-991-0835 Ext. 224
Copyright © Liquidia Technologies
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Aspen Aerogels, Inc. to Present at Barclays CEO Energy-Power Conference August 27th, 2014
Harris & Harris Group Letter to Shareholders on Website August 19th, 2014
Harris & Harris Group to Host Conference Call on Second-Quarter 2014 Financial Results on August 15, 2014 August 12th, 2014
Aspen Aerogels, Inc. to Present at Canaccord Genuity 34th Annual Growth Conference August 11th, 2014
Nanoscale assembly line August 29th, 2014
Copper shines as flexible conductor August 29th, 2014
Novel 'butterfly' molecule could build new sensors, photoenergy conversion devices August 28th, 2014
PetLife Comments on CNN Story on Scorpion Venom Health Benefits August 27th, 2014
Fonon Announces 3D Metal Sintering Technology: Emerging Additive Nano Powder Manufacturing Technology August 28th, 2014
SouthWest NanoTechnologies CEO Dave Arthur to Discuss “Carbon Nanotubes and Automotive Applications” at The Automotive Composites Conference and Expo 2014 (ACCE2014) August 28th, 2014
Nanodiamonds Are Forever: A UCSB professor’s research examines 13,000-year-old nanodiamonds from multiple locations across three continents August 27th, 2014
Competition for Graphene: Berkeley Lab Researchers Demonstrate Ultrafast Charge Transfer in New Family of 2D Semiconductors August 26th, 2014
A new, tunable device for spintronics: An international team of scientists including physicist Jairo Sinova from the University of Mainz realises a tunable spin-charge converter made of GaAs August 29th, 2014
Nanoscale assembly line August 29th, 2014
New analytical technology reveals 'nanomechanical' surface traits August 29th, 2014
New Vice President Takes Helm at CNSE CMOST: Catherine Gilbert To Lead CNSE Children’s Museum of Science and Technology Through Expansion And Relocation August 29th, 2014